Dr. Rosenberg said that before Kite, a few companies, including Johnson   Johnson, had looked at an earlier version of his technology but were wary because treatment involved processing each patientâ€™s cells.    technology available to be licensed to companies is posted on the website of the National Institutes of Health. And when the agency intends to grant a license to a particular company, it publishes that in the Federal Register, inviting public comment and possible competing offers. 